PR

MEZOO, connecting health through technology
Sharing MEZOO’s technology and vision.
External
2026.02.10
[Biz Interview] Mezoo: “Speeding Up U.S. Expansion After IPO”

 

[Anchor]

Mezoo, a mobile remote patient monitoring company, is set to be listed on the KOSDAQ market next month.

As the AI-based wearable monitoring market is still in its early stages, attention is focused on how competition for market share will unfold going forward. What competitive strengths does Mezoo bring to the table?

Reporter Kim Hyoseon sat down with CEO Park Jeong-hwan to hear more.

 

[Reporter]

Mezoo is a mobile remote patient monitoring solutions company that enables real-time measurement, analysis, transmission, and management of patients’ vital signs.

In particular, the company is moving to strengthen its technological competitiveness by accelerating its entry into the U.S. market after listing, while also announcing the launch of new products capable of measuring multiple biometric indicators with a single device.

We take a closer look at Mezoo’s growth vision.


Source : https://www.paxetv.com/news/articleView.html?idxno=261477

 

적용 법률 및 규정
의료기기

하이카디® 시스템은 인허가에 따라 신생아, 소아, 청소년, 18세 이상 환자의 ECG 데이터를 측정하여 부정맥을 진단하는 의료기기로서 의료전문가가 사용하도록 설계되었습니다. 한국 KFDA로부터 의료기기 2등급 인증을 받았습니다. 유럽의료기기 지침(2007/47/EC에 따라 개정된 MDD 93/42/EEC)에 따라 준수된 Class IIb (CE2265). 의료기기 제품으로 CE 승인되었습니다. 미국 FDA는 Class II 510K로 승인 완료 예정입니다.

경고

본 자료는 의료 전문가에게만 배포되며 관련 사진과 함께 제공되는 자료와 관련하여 그 어떤 법적인 책임을 갖지 않습니다. 사용 전 사용 지침서를 주의 깊게 읽으십시오.